Pricing Log in Create free account

Atara Biotherapeutics, Inc. (ATRA) vs Tiziana Life Sciences Ltd (TLSA)

Atara Biotherapeutics, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Atara Biotherapeutics, Inc. and Tiziana Life Sciences Ltd are of similar size ($84.0M and $81.9M). Tiziana Life Sciences Ltd has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Atara Biotherapeutics, Inc. leads on 6 and Tiziana Life Sciences Ltd on 4.

Valuation

Metric ATRA TLSA Biotechnology median
P/E n/m n/m 10.26
P/S 19.54 — 9.18
P/B n/m n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.04 0.65
EV/Sales 17.94 n/m 8.98
Earnings yield (14.66%) (84.48%) (34.89%)
Free cash flow yield (17.38%) 0.00% (24.52%)

Profitability

Metric ATRA TLSA Biotechnology median
Gross margin 91.38% 0.00% 65.16%
Operating margin (229.67%) — 0.00%
Net margin (269.42%) 0.00% 0.00%
Free cash flow margin (353.49%) 0.00% 0.00%
Return on equity 46.33% 0.00% (50.12%)
Return on assets (57.62%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATRA TLSA Biotechnology median
Revenue growth (TTM) (96.72%) — 6.26%
EPS growth (last fiscal year) 122.52% (45.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATRA TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.98 0.76 4.89
Net debt to EBITDA (0.22) 0.19 1.01

Dividend

Metric ATRA TLSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATRA TLSA Biotechnology median
Market cap 84.02m 81.86m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack